Psoriasis Biologics Guidelines and Care Improvement Strategies
Resident's Online Coding Education
Basic Dermatology Curriculum ( 2-Week Rotation)
Basic Dermatology Curriculum (3-Week Rotation) for Internists
Basic Dermatology Curriculum (3-Week Rotation) for Pediatricians
Basic Dermatology Curriculum (4-Week Rotation)
Basic Dermatology Curriculum (All Modules)
Basic Dermatology Curriculum (Videos)
Cutaneous Lupus Erythematosus and Dermatomyositis
Morphea and Systemic Sclerosis
Hands on at Home: Dermatology Suture Techniques
Managing Co-Morbidities Associated with Psoriasis and Care Improvement Strategy
Prior Authorization: What a Pain!
Autoimmune Connective Tissue Disease and Vasculitis Education Program
Boards Fodder Flashcards (Sample Pack)
Board Prep Plus
Clinical Photography for Skin of Color
Introduction to Quality Improvement and Patient Safety in Dermatology: Phototherapy
Skin of Color Curriculum
Essentials of Pediatric Dermatology - Online Module
Teledermatology and COVID-19 Survey
Dialogues in Dermatology: Severe Cutaneous Adverse Reactions
Dialogues in Dermatology: Dermatologic Side Effects of Anticancer Drugs in 2020: What You Need To Know
Dialogues in Dermatology: Diagnostic Errors and Lessons From Medical Dermatology Referrals
Dialogues in Dermatology: Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
Dialogues in Dermatology: Controversies and Difficult Questions Concerning Biologic Therapeutics
Dialogues in Dermatology: JAAD Game Changers: Oral Tranexamic Acid (TA) in the Treatment of Melasma: A Retrospective Analysis
Dialogues in Dermatology: How Far Can We Get With Medical Imaging?
Dialogues in Dermatology: LGBTQ/SGM Health in Dermatology: Essentials and Updates
Dialogues in Dermatology: What To Do When Patch Testing is Negative
Dialogues in Dermatology: Chronic Urticaria and Angioedema: What’s New in Pathogenesis and Treatment
Dialogues in Dermatology: Machine Learning in Dermatology
Dialogues in Dermatology: Alternative/Complementary Medicine Related to Derm Conditions
Dialogues in Dermatology: New and Emerging Therapies: Itch
Dialogues in Dermatology: Hair Loss in Women 2021 Update
Dialogues in Dermatology: What’s New in Energy-Based Devices
Dialogues in Dermatology: Meditation/Stress Relief and Dermatologic Conditions
Dialogues in Dermatology: Inflammatory Skin Diseases: The Translational Revolution
Dialogues in Dermatology: What’s New in Blistering Diseases, Diagnostics
Dialogues in Dermatology: Melanoma Monday: What’s New in Melanoma?
Dialogues in Dermatology: Creative Therapeutics for Recalcitrant Dermatoses
Dialogues in Dermatology: Therapeutic Uses of Botulinum Toxin
Dialogues in Dermatology: Diversity in the Dermatologic Workplace
Dialogues in Dermatology: New Advances in CCCA
Dialogues in Dermatology: New Advances in Melasma
Dialogues in Dermatology: Off-Label Uses for Botulinum Toxin
Dialogues in Dermatology: New Advances in Cellulite Treatment
Dialogues in Dermatology: Male Genital Dermatology: Lessons Learned From a Male Genital Skin Disease Clinic
Dialogues in Dermatology: Vulvar Dermatology
Dialogues in Dermatology: Lichen Planus
Dialogues in Dermatology: Skin Conditions in Down Syndrome
Dialogues in Dermatology: Solving the Genetic Syndrome Puzzle
Dialogues in Dermatology: Cutting Edge Multidisciplinary Care of the CTCL Patient
Dialogues in Dermatology: Approach to pigmented lesions
Dialogues in Dermatology: Avoiding Complications and Maximizing Results in Laser Surgery
Dialogues in Dermatology: Caring for the Cancer Patient: Updates in Cutaneous Oncology
Dialogues in Dermatology: Clinical Trials in Dermatology
Dialogues in Dermatology: Comprehensive Approach to Neuromodulators and Fillers
Dialogues in Dermatology: Cosmetic Concerns and Considerations
Dialogues in Dermatology: Dermatologic Care of Refugee Populations
Dialogues in Dermatology: Dermoscopy-Learning from Easy and Difficult Cases
Dialogues in Dermatology: Dietary Triggers and Modifications of Common Dermatologic Conditions
Dialogues in Dermatology: Do I Order the ANA By Multiplex or IFA
Dialogues in Dermatology: Dysplastic Nevi for Dummies
Dialogues in Dermatology: Emerging New Therapies
Dialogues in Dermatology: Global Health Dermatology
Dialogues in Dermatology: Hair Disorders Made Easier
Dialogues in Dermatology: Hidradenitis Suppurativa
Dialogues in Dermatology: High Risk Squamous Cell Carcinoma
Dialogues in Dermatology: Hit Me With Your Best Shot
Dialogues in Dermatology: Inpatient Consultative Dermatology
Dialogues in Dermatology: Keloids
Dialogues in Dermatology: Lessons in CPC: Learning from Diagnostic Errors in Dermatopathology
Dialogues in Dermatology: Managing Non-Melanoma Skin Cancer in Very Elderly Patients
Dialogues in Dermatology: Nails
Dialogues in Dermatology: New and Emerging Therapies with Platelet-Rich Plasma
Dialogues in Dermatology: Patient Voice Pemphigus Vulgaris
Dialogues in Dermatology: Physician Burnout
Dialogues in Dermatology: Pigmented Lesions
Dialogues in Dermatology: Pigmented Potpourri – How To Evaluate, Diagnose, and Treat Pigmentary Conditions
Dialogues in Dermatology: Practical Management of Birthmarks and Hamartomas
Dialogues in Dermatology: Practical to Cutting Edge: How to Care for our CTCL Patients
Dialogues in Dermatology: Professionalism in Dermatology
Dialogues in Dermatology: Psoriasis: Advances in Comorbidities and Therapy
Dialogues in Dermatology: Public Health & Dermatology
Dialogues in Dermatology: Skin of Color Boot Camp 8.24.20
Dialogues in Dermatology: Skin of Color Through the Ages
Dialogues in Dermatology: Staying General in Dermatology
Dialogues in Dermatology: The Changing Landscape of Early Stage Melanoma Management
Dialogues in Dermatology: What’s New in Acne
Dialogues in Dermatology: What’s New in Wound Care
Dialogues in Dermatology: What's That? Syndrome Update
Dialogues in Dermatology: Women’s Health Therapeutic Hotline
Dialogues in Dermatology: Off-Label Use of Biologics and New Medications
Dialogues in Dermatology: Alopecia Areata
Dialogues in Dermatology: JAAD Game Changer: Standardized Laboratory Monitoring with Use of Isotretinoin in Acne
Dialogues in Dermatology: Body Dysmorphic Disorder
Dialogues in Dermatology: What’s New in Blistering Diseases, Therapeutics
Dialogues in Dermatology: Soft Tissue Augmentation and Neurotoxins in Patients of Skin of Color
Dialogues in Dermatology: Keloidal and Hypertrophic Scarring
Dialogues in Dermatology: Pearls for Surveillance and Management of High-Risk Skin Cancer Patients
Dialogues in Dermatology: Scars: What Have We Learned and Where are We Going?
Dialogues in Dermatology: Hand and Foot Psoriasis, Dermatitis and Other Inflammatory Dermatoses
Dialogues in Dermatology: Pigmentary Disorders: Longitudinal Melanonychia
Dialogues in Dermatology: Advances in the Treatment of Androgenetic Alopecia: Part I
Dialogues in Dermatology: Severe Exacerbations/Inpatient Presentation of Common Dermatoses
Dialogues in Dermatology: Updates in Hair Disorders
Dialogues in Dermatology: What’s New in the Pediatric Dermatology Toolbox
Dialogues in Dermatology: What’s New In Skin of Color
Dialogues in Dermatology: Where Do We Stand? The Pathogenesis and Treatment of Melasma
Dialogues in Dermatology: Psychodermatology
Dialogues in Dermatology: Phototherapy for Psoriasis in the Age of Biologics
Dialogues in Dermatology: Systemic Sclerosis
JAAD 1/21 Reflectance Confocal Microscopy. Diagnostic criteria of common benign and malignant neoplasms, dermoscopic and histopathologic correlates of key confocal criteria, and diagnostic algorithms
JAAD 1/21 Reflectance confocal microscopy: Principles, basic terminology, clinical indications, limitations, and practical considerations
JAAD 2/21 Pediatric Allergic Contact Dermatitis. Part I. Clinical Features and Common Contact Allergens in Children
JAAD 2/21 Pediatric Allergic Contact Dermatitis. Part II. Patch Testing Series, Procedure, and Unique Scenarios
JAAD 3/21 The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication
JAAD 3/21 The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part II, Current and Future Approaches
JAAD 04/21: Preventing complications in dermatologic surgery: Presurgical concerns
JAAD 04/21 Preventing and managing complications in dermatologic surgery: Procedural and postsurgical concerns
JAAD 5/21 Visible Light Part I. Properties and Cutaneous Effects of Visible Light
JAAD 5/21 Visible Light Part II. Photoprotection against visible and ultraviolet light
JAAD 6/21 Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
JAAD 6/21 Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy
JAAD 7/21 Subepidermal Autoimmune Blistering Dermatoses: Clinical Features and Diagnosis
JAAD 7/21 Subepithelial Autoimmune Bullous Dermatoses Disease Activity Assessment and Therapy
JAAD 8/21 In-Vitro Diagnostics for the Medical Dermatologist: Part 1: Autoimmune Tests
JAAD 8/21 In-Vitro Diagnostics for the Medical Dermatologist: Part 2: Hypercoagulability Tests
JAAD 9/21 Radiation therapy in the treatment of cutaneous malignancies. Part I: Diagnostic modalities and applications
JAAD 9/21 Radiation therapy in the treatment of cutaneous malignancies. Part II: Indications, efficacy, safety
JAAD 10/21 Part I. Hair Transplantation: Basic Overview
JAAD 10/21 Part II. Hair Transplantation: Surgical Technique
JAAD 11/21 Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome – Part I: Clinical and histologic features and diagnosis
JAAD 11/21 Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome. Part II: Prognosis and Management
JAAD 12/21 Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment.
JAAD 12/21 Infantile hemangioma. Part 2: Management
JAAD 03/20 Ectoparasites: Scabies
JAAD 03/20 Pediculosis and tungiasis
JAAD 04/20 Retiform purpura: A diagnostic approach
JAAD 04/20 Retiform purpura: Workup and therapeutic considerations in select conditions
JAAD 05/20 Hidradenitis suppurativa: Current and emerging treatments
JAAD 05/20 Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis
JAAD 06/20 Vulvar diseases: Approach to the Patient
JAAD 06/20 Vulvar diseases: Conditions in adults and children
JAAD 07/20 Leprosy: Clinical aspects and diagnostic techniques
JAAD 07/20 Leprosy: Treatment and Management of Complications
JAAD 08/20 Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with lupus erythematosus
JAAD 08/20 Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis
JAAD 09/20 Field Cancerization: Definition, epidemiology, risk factors, and outcomes
JAAD 09/20 Field Cancerization: Treatment
JAAD 10/20 Technological advances for the detection of melanoma Part I. Advances in imaging techniques
JAAD 10/20 Technological advances for the detection of melanoma Part II. Advances in molecular techniques
JAAD 11/20 Part I: Immune checkpoint inhibitors to treat cutaneous malignancies
JAAD 11/20 Part II: Immune checkpoint inhibitor-related dermatologic adverse events
JAAD 12/20 Prurigo Nodularis: Epidemiology and Clinical Features
JAAD 12/20 Prurigo Nodularis: Pathogenesis and Management
JDCR Case Challenge - January 2021
JDCR Case Challenge - February 2021
JDCR Case Challenge - March 2021
JDCR Case Challenge - April 2021
JDCR Case Challenge - May 2021
JDCR Case Challenge - June 2021
JDCR Case Challenge - July 2021
JDCR Case Challenge - August 2021
JDCR Case Challenge - April 2020
JDCR Case Challenge - May 2020
JDCR Case Challenge - June 2020
JDCR Case Challenge - July 2020
JDCR Case Challenge - August 2020
JDCR Case Challenge - September 2020
JDCR Case Challenge - October 2020
JDCR Case Challenge - November 2020
JDCR Case Challenge - December 2020
JDCR Case Challenge - September 2021
JDCR Case Challenge - October 2021
JDCR Case Challenge - November 2021
JDCR Case Challenge - December 2021
Core Curriculum
Ethical Dilemmas in Dermatology
Dialogues in Dermatology: Facial Anatomy Danger Zones
Question of the Week Self-Assessment - 2022
JAAD 01/22 Itch: epidemiology, clinical presentation, and diagnostic workup
JAAD 01/22 Itch: pathogenesis and treatment
JDCR Case Challenge - January, 2022
Dialogues in Dermatology: Skin Conditions in Asian Patients That You Do Not Want to Miss
Dialogues in Dermatology: Allergic Contact Dermatitis
Vasculitis
Dialogues in Dermatology: Comorbidities and Psoriasis
Dialogues in Dermatology: JAAD Game Changer: Comparative Effectiveness of Biologic Agents for the Treatment of Psoriasis in a Real-World Setting: Results from a Large, Prospective, Observational Study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Dialogues in Dermatology: Advances in Treatment of Androgenetic Alopecia: Part II
Dialogues in Dermatology: Practice with a Purpose and Never Burn Out
JAAD 02/22 The Epidemiology, Impact, and Diagnosis of Micronutrient Nutritional Dermatoses Part 1: Zinc, Selenium, Copper, Vitamin A, and Vitamin C
JAAD 02/22 The Epidemiology, Impact, and Diagnosis of Micronutrient Nutritional Dermatoses Part 2: B-Complex Vitamins
Dialogues in Dermatology: Malignant Melanoma: Molecular Diagnostics, Emerging Therapies, and the Microbiome
Dialogues in Dermatology: Acute and Chronic Pain Management in Dermatology
JAAD 03/22 Melanoma: How and When to Consider Clinical Diagnostic Technologies
2022 - eCompliance Series - HIPAA Training for Medical Office Module
2022 - eCompliance Series - OSHA Training for Medical Office Module
JAAD 03/22 Melanoma: An Update on Systemic Therapies
Dialogues in Dermatology: New Common Allergens in Personal Care Products
Dialogues in Dermatology: Oncodermatology
JDCR Case Challenge - February, 2022
Dialogues in Dermatology: Sclerotherapy Update and Review
JDCR Case Challenge - March, 2022
Question of the Week Self-Assessment - 2023
JAAD 04/22 An Update on Cosmetic Procedures in People of Color Part 1: Scientific background, assessment, pre-procedure preparation
JAAD 04/22 An Update on Cosmetic Procedures in People of Color Part 2: Neuromodulators, Soft Tissue Augmentation, Chemexfoliating Agents, and Laser Hair Reduction
JAAD 05/22 Calciphylaxis: Diagnosis and Pathology
JAAD 05/22 Calciphylaxis: Treatment and Outlook
Dialogues in Dermatology: FISH and CGH in Melanocytic Lesions
Dialogues in Dermatology: Non-Invasive Imaging in Dermatology
Dialogues in Dermatology: Mast Cell Diseases
Dialogues in Dermatology: What You Should Know About Management of High-Risk Squamous Cell Carcinoma
Psoriasis Phototherapy Guidelines and Care Improvement Strategies
Career Launch Boot Camp Collection
JDCR Case Challenge April, 2022
Dialogues in Dermatology: Fractionated Non-Ablative and Ablative Lasers in Skin of Color
Dialogues in Dermatology: New Topical Therapies for Psoriasis
2022 - eCompliance Series - Preparing for the CLIA Inspection Module
JAAD 06/22 Part I: Antimicrobial resistance: bacterial pathogens of dermatologic significance and implications of rising resistance
JAAD 06/22 Antimicrobials and Resistance: Update for the Dermatologist (Part II: Antifungals, Antivirals, and Antiparasitics)
Dialogues in Dermatology: JAK Inhibitors
Dialogues in Dermatology: Rosacea Classification, Comorbidities and Therapeutics 2022
Dialogues in Dermatology: What’s New in the Treatment of Hidradenitis Suppurativa
JAAD 07/22 Emerging Therapeutics in the Management of Connective Tissue Disease. Part I. Lupus Erythematosus and Sjögren’s Syndrome
JAAD 07/22 Emerging Therapeutics in the Management of Connective Tissue Disease. Part II. Dermatomyositis and Scleroderma
Dialogues in Dermatology: Melanoma Literature Update
Dialogues in Dermatology: Treatment of Moderate to Severe Rosacea
Dialogues in Dermatology: High Yield Tips for Care of Afro-Textured Hair
Dialogues in Dermatology: What's New in the Treatment of Warts?
Dialogues in Dermatology: GVHD
JAAD 08/22 Skin Cancer: Primary, Secondary, and Tertiary Prevention. Part I
JAAD 08/22 Skin Cancer: Primary, Secondary, and Tertiary Prevention. Part II
Dialogues in Dermatology: Rare Non-Melanoma Skin Cancer
Dialogues in Dermatology: In Office Radiation Treatment
JAAD 09/22 Cutaneous Manifestations of Child Abuse and Neglect: Part I
JAAD 09/22 Cutaneous mimics of child abuse and neglect: Part II
Dialogues in Dermatology: JAAD Game Changer: Dermoscopy of Black Skin
Dialogues in Dermatology: Understanding the Skin Barrier
Dialogues in Dermatology: Platelet-Rich Plasma
Dialogues in Dermatology: Herpes Zoster and Its Vaccine Nuances
Dialogues in Dermatology: Filler Rheology
Dialogues in Dermatology: Dermatologic Care for the Leukemia and Lymphoma Patient
Dialogues in Dermatology: Frontal Fibrosing Alopecia/Lichen Planopilaris
JAAD 10/22 Racial/Ethnic Health Disparities in Dermatology in the United States Part 1: Overview of Contributing Factors and Management Strategies
JAAD 10/22 Racial/Ethnic Health Disparities in Dermatology in the United States Part 2: Disease-specific Epidemiology, Characteristics, Management, and Outcomes
Dialogues in Dermatology: Gene Expression Profiling for Pigmented Lesions
Dialogues in Dermatology: Common Rare Tumors in Dermatology: Sebaceous Carcinoma, DFSP, EMPD—Diagnostic and Management Considerations
Dialogues in Dermatology: Appropriate Use Criteria in Dermatopathology: What Do They Mean for Dermatology?
JAAD 11/22 Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
JAAD 11/22 Systemic sclerosis in adults. Part II: Management and therapeutics
Dialogues in Dermatology: Acquired Dermal Macular Pigmentation: Where Do We Stand?
Dialogues in Dermatology: Advanced Therapeutics for Melanoma
Dialogues in Dermatology: New Medications Used in Primary Care and Their Dermatologic Side Effects
JAAD 12/22 Variations in Genetics, Biology, and Phenotype of Cutaneous Disorders in Skin of Color. Part I: Genetic, Biological, and Structural Differences in Skin of Color
JAAD 12/22 Variations in Genetics, Biology, and Phenotype of Cutaneous Disorders in Skin of Color. Part II: Differences in Clinical Presentation and Disparities in Cutaneous Disorders in Skin of Color
Dialogues in Dermatology: Skin Microbiome
Dialogues in Dermatology: Cell Transplant in Vitiligo
Dialogues in Dermatology: Vaccinations
Dialogues in Dermatology: Diseases of the Oral Mucosa
Dialogues in Dermatology: Home Use Devices – Sorting Out What Works
JAAD 01/23 Dysplastic Nevus Part I: Historical Perspective, Classification, and Epidemiology
JAAD 01/23 Dysplastic Nevus Part II: Dysplastic Nevi: Molecular/Genetic Profiles and Management
Dialogues in Dermatology: Getting the Most Out of Your Biopsies
Dialogues in Dermatology: Steroid Side Effects
Dialogues in Dermatology: High-Risk SCC Workup/Management
Dialogues in Dermatology: Alopecia Areata
Dialogues in Dermatology: A Clinician’s Perspective: Commentaries from the Journal of the American Academy of Dermatology
JAAD 02/23 Disorders of Hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders
JAAD 02/23 Disorders of Hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation
Dialogues in Dermatology: New Topical Therapies for Atopic Dermatitis
Guidelines of Care for the Management and Treatment of Pediatric Psoriasis
Psoriasis Topicals and Non-Biologics Care Improvement Strategies: Guidelines
Dialogues in Dermatology: Nail Diseases
Dialogues in Dermatology: Back to the Future in the Dermatologist’s Office
Implementing Quality Practices to Avoid Medication Error for Methotrexate Use
Dialogues in Dermatology: Adjunctive Therapies for Hidradenitis
JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids
JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors
Dialogues in Dermatology: Lessons in CPC, Learning from Diagnostic Errors in Dermatopathology
Dialogues in Dermatology: New Advances in Vitiligo
2023 - eCompliance Series - Preparing for the CLIA Inspection Module
Dialogues in Dermatology: Mind-Body Therapies as a Treatment Strategy in Dermatology: What is the Evidence?
Dialogues in Dermatology: Cosmetic Dermatology Innovations: From Topicals to Injectables and Devices
Dialogues in Dermatology: Somatic Mutations in Inflammatory Dermatosis
Dialogues in Dermatology: Pediatric Dermatology: Horses and Zebras
Genital Skin Exam
Dialogues in Dermatology: FDA for Dermatologists
Dialogues Template for 2023
Dialogues Template for 2023
Dialogues in Dermatology: Using and Understanding Light in Dermatology
2023 - eCompliance Series - HIPAA Training for Medical Office Module
2023 - eCompliance Series - OSHA Training for Medical Office Module
ABD_Question_Writing_Guide

PDF
AAD Learning Center Orientation Video